Cargando…
Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy
OBJECTIVE: We hypothesized that intranasal insulin (I-I) delivery targets the nervous system while avoiding potential adverse systemic effects when compared with subcutaneous insulin (S-I) for experimental streptozotocin-induced diabetic peripheral neuropathy (DPN). RESEARCH DESIGN AND METHODS: I-I...
Autores principales: | Francis, George, Martinez, Jose, Liu, Wei, Nguyen, Thuhien, Ayer, Amit, Fine, Jared, Zochodne, Douglas, Hanson, Leah R., Frey, William H., Toth, Cory |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661595/ https://www.ncbi.nlm.nih.gov/pubmed/19136650 http://dx.doi.org/10.2337/db08-1287 |
Ejemplares similares
-
Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy. Diabetes 2009;58:934–945. DOI: 10.2337/db08-1287
por: Francis, George, et al.
Publicado: (2014) -
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
por: Kosyakovsky, Jacob, et al.
Publicado: (2021) -
Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications
por: Kobayashi, Masaki, et al.
Publicado: (2018) -
Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome
por: Rosenbloom, Michael, et al.
Publicado: (2020) -
Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
por: Zhu, Yuan, et al.
Publicado: (2021)